Agile Therapeutics, Inc. (AGRX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous Close | 0.3060 |
| Open | 0.2865 |
| Bid | 0.2810 x 800 |
| Ask | 0.2840 x 1800 |
| Day's Range | 0.2600 - 0.3000 |
| 52 Week Range | 0.1750 - 15.6000 |
| Volume | |
| Avg. Volume | 935,873 |
| Market Cap | 10.942M |
| Beta (5Y Monthly) | 1.01 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -26.1610 |
| Earnings Date | Mar 28, 2023 - Apr 03, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.00 |
- GlobeNewswire
Agile Therapeutics Announces Distribution of Series C Preferred Stock to its Holders of Common Stock
PRINCETON, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series C Preferred Stock, par value $0.0001 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on February 6, 2023. The shares of Series C Preferred Stock will be distributed to such recipients at 5:0
- News Direct
Agile Therapeutics: This BioPharma Firm Is Nimbly Solving Unmet Needs For Women
By Johnny Rice, Benzinga
- Zacks
Is Ardelyx (ARDX) Outperforming Other Medical Stocks This Year?
Here is how Ardelyx (ARDX) and Agile Therapeutics (AGRX) have performed compared to their sector so far this year.
© 2023 Yahoo. All rights reserved.
